Cited by 180SARS-CoV-2 and COVID-19 ResearchRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus Research

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases

Spiera, Robert, Jinich, Sarah, Jannat-Khah, Deanna·2021·Annals of the Rheumatic Diseases

Overview

Integrity signals

Registry

Crossref · 10.1136/annrheumdis-2021-220604

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 6 references

Metadata

Authors
Spiera, R., Jinich, S., & Jannat-Khah, D.
Affiliations
Hospital for Special Surgery (US)
Corresponding author
Spiera, Robert
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2021-10
Volume
80
Issue
10
Pages
1357-1359
ISSN
0003-4967 (ISSN-L)
OpenAlex
W3162898139
Cited by
180
References
6
Citations by year
2026: 3 · 2025: 9 · 2024: 14 · 2023: 28 · 2022: 68 · 2021: 58
FWCI
13.24
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of the Rheumatic Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Keywords
rituximab, COVID-19 vaccination, serological response, rheumatic diseases, antirheumatic therapy, COVID-19 pandemic, informal caregivers, mental health, COVID-19 lockdown, caregiver burden, carer support services, learning difficulties, spousal caregivers
MeSH terms
Rituximab, Immunogenicity, Vaccine, COVID-19, SARS-CoV-2, COVID-19 Vaccines, Adult, Aged, Antibodies, Viral, Female, Humans, Male, Middle Aged, Retrospective Studies, Rheumatic Diseases, Immunocompromised Host, Antirheumatic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review